Clinical Trial Update: Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atomoxetine hydrochloride to placebo in Taiwanese children and adolescents with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine hydrochloride (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED